{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T05:51:27Z","timestamp":1791697887447,"version":"4.3.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Equine Veterinary Science"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jevs.2021.103810","type":"journal-article","created":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T00:06:20Z","timestamp":1636848380000},"page":"103810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Circulating Hypothalamic-Pituitary-Adrenal Axis Hormones and Insulin Concentrations in Horses and Ponies"],"prefix":"10.1016","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8347-7247","authenticated-orcid":false,"given":"Sarah A.","family":"Vaughn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie A.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4331-6470","authenticated-orcid":false,"given":"Kelsey A.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jevs.2021.103810_bib0001","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1939-1676.2010.0503.x","article-title":"Equine metabolic syndrome","volume":"24","author":"Frank","year":"2010","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jevs.2021.103810_bib0002","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cveq.2010.12.007","article-title":"Equine pituitary pars intermedia dysfunction","volume":"27","author":"McFarlane","year":"2011","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1016\/j.jevs.2021.103810_bib0004","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/jvim.12056","article-title":"Adiposity, plasma insulin, leptin, lipids, and oxidative stress in mature light breed horses","volume":"27","author":"Pleasant","year":"2013","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jevs.2021.103810_bib0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/avj.12159","article-title":"Prevalence and risk factors for hyperinsulinaemia in ponies in Queensland, Australia","volume":"92","author":"Morgan","year":"2014","journal-title":"Aust Vet J"},{"key":"10.1016\/j.jevs.2021.103810_bib0006","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.2042-3306.2012.00578.x","article-title":"Prevalence, risk factors and clinical signs predictive for equine pituitary pars intermedia dysfunction in aged horses","volume":"45","author":"McGowan","year":"2013","journal-title":"Equine Vet J"},{"key":"10.1016\/j.jevs.2021.103810_bib0007","unstructured":"Equine Endocrinology Group. Consensus statement: recommendations for the diagnosis and treatment of equine metabolic syndrome (EMS). 2020. https:\/\/sites.tufts.edu\/equineendogroup\/files\/2020\/09\/200592_EMS_Recommendations_Bro-FINAL.pdf."},{"key":"10.1016\/j.jevs.2021.103810_bib0008","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.domaniend.2014.07.003","article-title":"Pituitary pars intermedia dysfunction does not necessarily impair insulin sensitivity in old horses","volume":"50","author":"Mastro","year":"2015","journal-title":"Domest Anim Endocrinol"},{"key":"10.1016\/j.jevs.2021.103810_bib0009","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/evj.13041","article-title":"Factors associated with survival, laminitis and insulin dysregulation in horses diagnosed with equine pituitary pars intermedia dysfunction","volume":"51","author":"Horn","year":"2019","journal-title":"Equine Vet J"},{"key":"10.1016\/j.jevs.2021.103810_bib0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.domaniend.2013.11.001","article-title":"Breed differences in insulin sensitivity and insulinemic responses to oral glucose in horses and ponies of moderate body condition score","volume":"47","author":"Bamford","year":"2014","journal-title":"Domest Anim Endocrinol"},{"key":"10.1016\/j.jevs.2021.103810_bib0011","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/avj.13022","article-title":"Circannual variation in plasma adrenocorticotropic hormone concentrations and dexamethasone suppression test results in Standardbred horses, Andalusian horses and mixed-breed ponies","volume":"98","author":"Bamford","year":"2020","journal-title":"Aust Vet J"},{"key":"10.1016\/j.jevs.2021.103810_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.jevs.2019.102793","article-title":"Glucose and insulin responses to an intravenous glucose load in thoroughbred and Paso Fino horses","volume":"81","author":"Breuhaus","year":"2019","journal-title":"J Equine Vet Sci"},{"key":"10.1016\/j.jevs.2021.103810_bib0014","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.2460\/javma.228.10.1538","article-title":"Evaluation of genetic and metabolic predispositions and nutritional risk factors for pasture-associated laminitis in ponies","volume":"228","author":"Treiber","year":"2006","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jevs.2021.103810_bib0015","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2746\/042516408X342975","article-title":"Prediction of incipient pasture-associated laminitis from hyperinsulinaemia, hyperleptinaemia and generalised and localised obesity in a cohort of ponies","volume":"41","author":"Carter","year":"2009","journal-title":"Equine Vet J"},{"key":"10.1016\/j.jevs.2021.103810_bib0016","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2460\/ajvr.69.1.122","article-title":"Hypertension and insulin resistance in a mixed-breed population of ponies predisposed to laminitis","volume":"69","author":"Bailey","year":"2008","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.jevs.2021.103810_bib0017","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.domaniend.2011.05.004","article-title":"The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion\/referral equine hospital","volume":"41","author":"Karikoski","year":"2011","journal-title":"Domest Anim Endocrinol"},{"issue":"4","key":"10.1016\/j.jevs.2021.103810_bib0018","first-page":"evj.13053","article-title":"Heritability of metabolic traits associated with equine metabolic syndrome in Welsh ponies and Morgan horses","volume":"51","author":"Norton","year":"2018","journal-title":"Equine Vet J"},{"key":"10.1016\/j.jevs.2021.103810_bib0019","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cveq.2010.04.001","article-title":"Corticosteroid-associated laminitis","volume":"26","author":"Bailey","year":"2010","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1016\/j.jevs.2021.103810_bib0020","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2460\/javma.231.9.1365","article-title":"Effect of dietary fructans and dexamethasone administration on the insulin response of ponies predisposed to laminitis","volume":"231","author":"Bailey","year":"2007","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jevs.2021.103810_bib0021","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cveq.2010.04.009","article-title":"Endocrinopathic laminitis","volume":"26","author":"McGowan","year":"2010","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1016\/j.jevs.2021.103810_bib0022","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/evj.12565","article-title":"Does oral prednisolone treatment increase the incidence of acute laminitis?","volume":"49","author":"VJ","year":"2017","journal-title":"Equine Vet J"},{"key":"10.1016\/j.jevs.2021.103810_bib0023","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/vr.105378","article-title":"Prevalence of and risk factors for acute laminitis in horses treated with corticosteroids","volume":"185","author":"Potter","year":"2019","journal-title":"Vet Rec"},{"key":"10.1016\/j.jevs.2021.103810_bib0024","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/jvim.12489","article-title":"Investigation of Single and Paired Measurements of Adrenocorticotropic Hormone for the Diagnosis of Pituitary Pars Intermedia Dysfunction in Horses","volume":"29","author":"Rendle","year":"2015","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jevs.2021.103810_bib0025","first-page":"287","article-title":"Pharmacokinetics and metabolic effects of triamcinolone acetonide and their possible relationships to glucocorticoid-induced laminitis in horses","volume":"23","author":"French","year":"2000","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.jevs.2021.103810_bib0026","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2527\/jas.2008-1179","article-title":"Effect of a single dose of dexamethasone on glucose homeostasis in healthy horses by using the combined intravenous glucose and insulin test1","volume":"87","author":"Haffner","year":"2009","journal-title":"J Anim Sci"},{"key":"10.1016\/j.jevs.2021.103810_bib0027","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2460\/ajvr.68.7.753","article-title":"Effects of dexamethasone on glucose dynamics and insulin sensitivity in healthy horses","volume":"68","author":"Tiley","year":"2007","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.jevs.2021.103810_bib0028","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2460\/ajvr.71.1.60","article-title":"Effects of pretreatment with dexamethasone or levothyroxine sodium on endotoxin-induced alterations in glucose and insulin dynamics in horses","volume":"71","author":"T\u00f3th","year":"2010","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.jevs.2021.103810_bib0029","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2460\/javma.1994.204.04.627","article-title":"Diagnostic testing for pituitary pars intermedia dysfunction in horses","volume":"204","author":"Dybdal","year":"1994","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jevs.2021.103810_bib0030","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/jvim.13839","article-title":"Effect of age, season, body condition, and endocrine status on serum free cortisol fraction and insulin concentration in horses","volume":"30","author":"Hart","year":"2016","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jevs.2021.103810_bib0031","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1939-1676.2011.0745.x","article-title":"The effect of geographic location, breed, and pituitary dysfunction on seasonal adrenocorticotropin and \u03b1-melanocyte-stimulating hormone plasma concentrations in horses","volume":"25","author":"McFarlane","year":"2011","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jevs.2021.103810_bib0032","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1939-1676.2010.0500.x","article-title":"Seasonal variation in serum concentrations of selected metabolic hormones in horses","volume":"24","author":"Place","year":"2010","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jevs.2021.103810_bib0033","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1210\/jc.2001-011843","article-title":"Serum corticosteroid-binding globulin concentration and insulin resistance syndrome: A population study","volume":"87","author":"Fernandez-Real","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jevs.2021.103810_bib0034","doi-asserted-by":"crossref","DOI":"10.1186\/1743-7075-2-3","article-title":"The role of glucocorticoid action in the pathophysiology of the metabolic syndrome","volume":"2","author":"Wang","year":"2005","journal-title":"Nutr Metab"},{"key":"10.1016\/j.jevs.2021.103810_bib0035","article-title":"Consensus statement: recommendations for the diagnosis and treatment of pituitary pars intermedia dysfunction (PPID)","year":"2019","journal-title":"Equine Endocrinology Group"},{"key":"10.1016\/j.jevs.2021.103810_bib0036","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.2042-3306.1983.tb01826.x","article-title":"Relationship between condition score, physical measurements and body fat percentage in mares","volume":"15","author":"Henneke","year":"1983","journal-title":"Equine Vet J"},{"key":"10.1016\/j.jevs.2021.103810_bib0038","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF00368462","article-title":"Validation and application of solid-phase chemiluminescent immunoassays for diagnosis of endocrine diseases in animals","volume":"6","author":"Reimers","year":"1996","journal-title":"Comp Haematol Int"},{"key":"10.1016\/j.jevs.2021.103810_bib0039","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/104063879700900307","article-title":"Validation of nonradioactive chemiluminescent immunoassay methods for the analysis of thyroxine and cortisol in blood samples obtained from dogs, cats, and horses","volume":"9","author":"Singh","year":"1997","journal-title":"J Vet Diagnostic Investig"},{"key":"10.1016\/j.jevs.2021.103810_bib0040","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1939-1676.2010.0667.x","article-title":"Serum free cortisol fraction in healthy and septic neonatal foals","volume":"25","author":"Hart","year":"2011","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jevs.2021.103810_bib0041","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.coph.2017.08.006","article-title":"Adipose tissue inflammation in obesity: a metabolic or immune response?","volume":"37","author":"Stolarczyk","year":"2017","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jevs.2021.103810_bib0042","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1530\/JOE-14-0283","article-title":"The role of adipose tissue immune cells in obesity and low-grade inflammation","volume":"222","author":"Mraz","year":"2014","journal-title":"J Endocrinol"},{"key":"10.1016\/j.jevs.2021.103810_bib0043","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201700036","article-title":"Inflammation and insulin resistance: New targets encourage new thinking","volume":"39","author":"Johnson","year":"2017","journal-title":"BioEssays"},{"key":"10.1016\/j.jevs.2021.103810_bib0044","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1210\/endo.133.1.8391424","article-title":"Interleukin-6 inhibits corticosteroid-binding globulin synthesis by human hepatoblastoma-derived (Hep g2) cells","volume":"133","author":"Bartalena","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.jevs.2021.103810_bib0045","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/00003246-199803000-00014","article-title":"Decreased corticosteroid-binding globulin in burn patients: Relationship with interleukin-6 and fat in nutritional support","volume":"26","author":"Bernier","year":"1998","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jevs.2021.103810_bib0046","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/cen.12680","article-title":"Depletion of high-affinity corticosteroid-binding globulin corresponds to illness severity in sepsis and septic shock; clinical implications","volume":"82","author":"Nenke","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jevs.2021.103810_bib0047","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/oby.2005.179","article-title":"Corticosteroid binding globulin gene polymorphism influences cortisol driven fat distribution in obese women","volume":"13","author":"Barat","year":"2005","journal-title":"Obes Res"},{"key":"10.1016\/j.jevs.2021.103810_bib0048","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/me.2004-0005","article-title":"Corticosteroid binding globulin: a new target for cortisol-driven obesity","volume":"18","author":"Ousova","year":"2004","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jevs.2021.103810_bib0049","series-title":"Williams textbook of endocrinology","first-page":"445","article-title":"The adrenal cortex","author":"Stewart","year":"2008"},{"key":"10.1016\/j.jevs.2021.103810_bib0050","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1210\/jc.2009-0370","article-title":"The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis","volume":"94","author":"Anagnostis","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jevs.2021.103810_bib0051","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2265.2000.00864.x","article-title":"The insulin resistance syndrome and the binding capacity of cortisol binding globulin (CBG) in men and women","volume":"52","author":"Fern\u00e1ndez-Real","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jevs.2021.103810_bib0052","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-4939-2895-8_5","article-title":"Regulation of glucose homeostasis by glucocorticoids","volume":"872","author":"Kuo","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jevs.2021.103810_bib0054","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1939-1676.2011.00810.x","article-title":"Comparison of cortisol and ACTH responses after administration of thyrotropin releasing hormone in normal horses and those with pituitary pars intermedia dysfunction","volume":"25","author":"Beech","year":"2011","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jevs.2021.103810_bib0055","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/evj.13292","article-title":"Clinically and temporally specific diagnostic thresholds for plasma ACTH in the horse","volume":"53","author":"Durham","year":"2021","journal-title":"Equine Vet J"},{"key":"10.1016\/j.jevs.2021.103810_bib0056","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.2042-3306.2011.00444.x","article-title":"Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction","volume":"44","author":"Copas","year":"2012","journal-title":"Equine Vet J"},{"key":"10.1016\/j.jevs.2021.103810_bib0057","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.domaniend.2012.05.005","article-title":"Circadian and circannual rhythms of cortisol, ACTH, and \u03b1-melanocyte-stimulating hormone in healthy horses","volume":"43","author":"Cordero","year":"2012","journal-title":"Domest Anim Endocrinol"},{"key":"10.1016\/j.jevs.2021.103810_bib0058","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/jvim.15423","article-title":"Consensus statement on equine metabolic syndrome","volume":"33","year":"2019","journal-title":"J Vet Intern Med"},{"issue":"2","key":"10.1016\/j.jevs.2021.103810_bib0059","doi-asserted-by":"crossref","DOI":"10.1111\/jvim.15403","article-title":"Evaluation of an HMGA2 variant for pleiotropic effects on height and metabolic traits in ponies","volume":"33","author":"Norton","year":"2019","journal-title":"J Vet Intern Med"}],"container-title":["Journal of Equine Veterinary Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0737080621004408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0737080621004408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:52:38Z","timestamp":1760032358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0737080621004408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":55,"alternative-id":["S0737080621004408"],"URL":"https:\/\/doi.org\/10.1016\/j.jevs.2021.103810","relation":{},"ISSN":["0737-0806"],"issn-type":[{"value":"0737-0806","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating Hypothalamic-Pituitary-Adrenal Axis Hormones and Insulin Concentrations in Horses and Ponies","name":"articletitle","label":"Article Title"},{"value":"Journal of Equine Veterinary Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jevs.2021.103810","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103810"}}